Intech Investment Management LLC increased its stake in shares of Exponent, Inc. (NASDAQ:EXPO - Free Report) by 220.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 25,973 shares of the business services provider's stock after purchasing an additional 17,880 shares during the period. Intech Investment Management LLC owned 0.05% of Exponent worth $2,314,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Cibc World Markets Corp acquired a new position in Exponent in the 4th quarter valued at about $421,000. Royce & Associates LP grew its holdings in shares of Exponent by 8.1% during the fourth quarter. Royce & Associates LP now owns 202,981 shares of the business services provider's stock worth $18,086,000 after buying an additional 15,255 shares in the last quarter. Atala Financial Inc acquired a new position in shares of Exponent in the fourth quarter valued at approximately $25,000. Impact Capital Partners LLC purchased a new position in shares of Exponent during the fourth quarter valued at approximately $379,000. Finally, Swiss National Bank boosted its position in Exponent by 0.8% during the fourth quarter. Swiss National Bank now owns 99,800 shares of the business services provider's stock worth $8,892,000 after acquiring an additional 800 shares during the last quarter. Hedge funds and other institutional investors own 92.37% of the company's stock.
Exponent Stock Down 0.2 %
Shares of NASDAQ:EXPO traded down $0.14 during midday trading on Tuesday, reaching $80.05. The company's stock had a trading volume of 289,087 shares, compared to its average volume of 216,231. The firm has a market cap of $4.07 billion, a price-to-earnings ratio of 37.76 and a beta of 0.77. The business has a 50 day moving average price of $87.63 and a 200 day moving average price of $96.27. Exponent, Inc. has a 1 year low of $77.30 and a 1 year high of $115.75.
Exponent (NASDAQ:EXPO - Get Free Report) last announced its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.46 earnings per share for the quarter, beating analysts' consensus estimates of $0.40 by $0.06. Exponent had a net margin of 19.52% and a return on equity of 27.27%. During the same period last year, the firm posted $0.41 EPS. Sell-side analysts anticipate that Exponent, Inc. will post 1.98 earnings per share for the current fiscal year.
Insiders Place Their Bets
In related news, VP Richard Reiss sold 1,736 shares of the stock in a transaction that occurred on Wednesday, February 26th. The shares were sold at an average price of $85.93, for a total transaction of $149,174.48. Following the completion of the sale, the vice president now owns 1,800 shares of the company's stock, valued at approximately $154,674. This represents a 49.10 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.10% of the stock is currently owned by insiders.
Exponent Company Profile
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Further Reading

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.